Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Michael Paul Wakeman. (2017) An open-label forearm-controlled pilot study to assess the effect of a proprietary emollient formulation on objective parameters of skin function of eczema-prone individuals over 14 days. Clinical, Cosmetic and Investigational Dermatology 10, pages 275-283.
Read now
Read now
Kateřina Vávrová. (2016) Emerging small-molecule compounds for treatment of atopic dermatitis: a review. Expert Opinion on Therapeutic Patents 26:1, pages 21-34.
Read now
Read now
Kazutaka Sekiguchi, Kazuya Fukumura, Hiroshi Hasegawa & Takushi Kanazu. (2015) The metabolism and pharmacokinetics of [14C]-S-777469, a new cannabinoid receptor 2 selective agonist, in healthy human subjects. Xenobiotica 45:2, pages 150-157.
Read now
Read now
Kazutaka Sekiguchi, Takushi Kanazu, Masaharu Takeuchi, Hiroshi Hasegawa & Yoshitaka Yamaguchi. (2014) Non-clinical evaluation of the metabolism, pharmacokinetics and excretion of S-777469, a new cannabinoid receptor 2 selective agonist. Xenobiotica 44:1, pages 48-58.
Read now
Read now
Peck Y Ong. (2012) Editorial update on emerging treatments of atopic dermatitis. Expert Opinion on Emerging Drugs 17:2, pages 129-133.
Read now
Read now
Articles from other publishers (24)
Ranjit Kumar Mahato, Mohini Singh, Hemanta Pathak, Niva Rani Gogoi, Rikynjai Kharbithai, Pinky Chowrasia, Pankaj Lochan Bora, Tumpa Sarkar, Bani Kumar Jana & Bhaskar Mazumder. (2023) Emerging nanotechnology backed formulations for the management of atopic dermatitis. Therapeutic Delivery 14:9, pages 543-569.
Crossref
Crossref
Janice A. Layhadi, Elizabeth Palmer, Hanisah Sharif & Mohamed H. Shamji. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
477
490
.
Laine Ludriksone, Dimitar Antonov, Sibylle Schliemann & Peter Elsner. 2021. Contact Dermatitis. Contact Dermatitis
1273
1297
.
Laine Ludriksone, Dimitar Antonov, Sibylle Schliemann & Peter Elsner. 2020. Contact Dermatitis. Contact Dermatitis
1
25
.
Janelle Pavlis & Gil Yosipovitch. (2017) Management of Itch in Atopic Dermatitis. American Journal of Clinical Dermatology 19:3, pages 319-332.
Crossref
Crossref
Jiali Zhong, Zhihong Liu, Xinxin Zhou & Jun Xu. (2017) Synergic Anti-Pruritus Mechanisms of Action for the Radix Sophorae Flavescentis and Fructus Cnidii Herbal Pair. Molecules 22:9, pages 1465.
Crossref
Crossref
Namita A. Gandhi, Brandy L. Bennett, Neil M. H. Graham, Gianluca Pirozzi, Neil Stahl & George D. Yancopoulos. (2015) Targeting key proximal drivers of type 2 inflammation in disease. Nature Reviews Drug Discovery 15:1, pages 35-50.
Crossref
Crossref
Hyun Jong Kim, Bongwoo Kim, Bu Man Park, Jeong Eun Jeon, Sin Hee Lee, Shivtaj Mann, Sung Ku Ahn, Seung-Phil Hong & Se Kyoo Jeong. (2015) Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model. International Journal of Dermatology 54:10, pages e401-e408.
Crossref
Crossref
Knut Schäkel, Thomas Döbel & Ina Bosselmann. (2014) Future treatment options for atopic dermatitis – Small molecules and beyond. Journal of Dermatological Science 73:2, pages 91-100.
Crossref
Crossref
S Heuston & NP Hyland. (2012) Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?. British Journal of Pharmacology 167:4, pages 732-740.
Crossref
Crossref
Elizabeth P. Chase & April W. Armstrong. (2012) Advances in Management of Atopic Dermatitis: New Therapies and Novel Uses of Existing Treatments. Seminars in Cutaneous Medicine and Surgery 31:1, pages 17-24.
Crossref
Crossref
Danielle Morello Park, Teresa Lúcia Lamano Carvalho, Janete Aparecida Anselmo Franci & Wilma Terezinha Anselmo-Lima. (2012) Influence of Treatment with Intranasal Corticosteroids on the Nasal Mucosa, Weight, and Corticosteroid Concentration in Rats. American Journal of Rhinology & Allergy 26:1, pages e46-e49.
Crossref
Crossref
Y. Valdman-Grinshpoun, D. Ben-Amitai & A. Zvulunov. (2012) Barrier-Restoring Therapies in Atopic Dermatitis: Current Approaches and Future Perspectives. Dermatology Research and Practice 2012, pages 1-6.
Crossref
Crossref
. 2012. Conn's Current Therapy 2012. Conn's Current Therapy 2012
187
277
.
Thomas Werfel & Alexander Kapp. 2012. Allergy. Allergy
263
286
.
Elia Mattarucchi, Eugenio Baraldi & Claude Guillou. (2012) Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. Biomedical Chromatography 26:1, pages 89-94.
Crossref
Crossref
Ruth Duncan & Rogerio Gaspar. (2011) Nanomedicine(s) under the Microscope. Molecular Pharmaceutics 8:6, pages 2101-2141.
Crossref
Crossref
Peter M. Elias & Joan S. Wakefield. (2010) Therapeutic Implications of a Barrier-Based Pathogenesis of Atopic Dermatitis. Clinical Reviews in Allergy & Immunology 41:3, pages 282-295.
Crossref
Crossref
Thaís B. Lima, Osmar N. Silva, Ludovico Migliolo, Carlos R. Souza-Filho, Eduardo G. Gonçalves, Ilka M. Vasconcelos, José T. A. Oliveira, André C. Amaral & Octávio L. Franco. (2011)
A Kunitz Proteinase Inhibitor from Corms of
Xanthosoma blandum
with Bactericidal Activity
. Journal of Natural Products 74:5, pages 969-975.
Crossref
Crossref
Gun-Dong Kim, Tae-Ho Kim, An-Hee Jang, Hyun-Jong Ahn, Yong Seek Park & Cheung-Seog Park. (2011) ?-Lipoic acid suppresses the development of DNFB-induced atopic dermatitis-like symptoms in NC/Nga mice. Experimental Dermatology 20:2, pages 97-101.
Crossref
Crossref
Dimitar Antonov, Sibylle Schliemann & Peter Elsner. 2011. Contact Dermatitis. Contact Dermatitis
963
983
.
Jukka Kervinen, Carl Crysler, Shariff Bayoumy, Marta C. Abad, John Spurlino, Ingrid Deckman, Michael N. Greco, Bruce E. Maryanoff & Lawrence de Garavilla. (2010) Potency variation of small-molecule chymase inhibitors across species. Biochemical Pharmacology 80:7, pages 1033-1041.
Crossref
Crossref
Peck Y. Ong & Mark Boguniewicz. (2010) Investigational and Unproven Therapies in Atopic Dermatitis. Immunology and Allergy Clinics of North America 30:3, pages 425-439.
Crossref
Crossref
Peter M. Elias. (2010) Therapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis. Annals of Dermatology 22:3, pages 245.
Crossref
Crossref